According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM) is ₹3.05 B. In 2022 the company made a revenue of -₹2.71 B a decrease over the revenue in the year 2021 that were of ₹1.16 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.